| 2024-12-04 | +61.5% | M&A | Seeking Alpha | Cross Country Healthcare stock soars on acquisition by Aya Healthcare for $18.61/share |
| 2024-12-04 | +61.5% | legal | SEC EDGAR | CCRN 8-K: 1.01, 7.01 (SEC Filing) |
| 2024-12-04 | +61.5% | M&A | Stock Titan | Aya Healthcare Acquires Cross Country in Massive $615M Deal with 67% Premium - Stock Titan |
| 2021-11-03 | +23.5% | legal | SEC EDGAR | CCRN 8-K: 2.02, 7.01 (SEC Filing) |
| 2021-08-04 | +22.8% | legal | SEC EDGAR | CCRN 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-11-01 | -17.0% | legal | SEC EDGAR | CCRN 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-11-07 | -15.9% | earnings | Seeking Alpha | Cross Country Healthcare, Inc. (CCRN) Q3 2024 Earnings Call Transcript |
| 2021-05-05 | +15.7% | legal | SEC EDGAR | CCRN 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-12-04 | -15.6% | M&A | Seeking Alpha | Cross Country Healthcare terminates Aya Holdings merger; Aya to pay $20M fee |
| 2025-12-04 | -15.6% | M&A | Stock Titan | Cross Country Healthcare (Nasdaq: CCRN) Gets $20M Fee as Aya Merger Terminated - Stock Titan |
| 2025-12-04 | -15.6% | M&A | Investing.com | Cross Country Healthcare to buy back shares after Aya merger collapse - Investing.com |
| 2025-12-04 | -15.6% | M&A | The Business Journals | Boca Raton company's $615 million merger terminated - The Business Journals |
| 2022-08-03 | -15.2% | legal | SEC EDGAR | CCRN 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-08-02 | -13.1% | legal | SEC EDGAR | CCRN 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-01-19 | -11.8% | legal | SEC EDGAR | CCRN 8-K: 2.02, 5.02, 8.01 (SEC Filing) |
| 2025-11-12 | -10.9% | legal | SEC EDGAR | CCRN 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-11-12 | -10.9% | earnings | Yahoo Finance | Cross Country Healthcare (CCRN) Lags Q3 Earnings and Revenue Estimates - Yahoo Finance |
| 2022-09-14 | +10.9% | legal | SEC EDGAR | CCRN 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-10-13 | +10.8% | M&A | Seeking Alpha | As The Clock Winds Down, Cross Country Healthcare Is At Its Cheapest Levels Since The Merger Announcement - Seeking Alpha |
| 2025-09-11 | -10.4% | news | Seeking Alpha | Cross Country Healthcare falls as FTC schedules meeting for next week |
| 2025-11-13 | -10.3% | earnings | Seeking Alpha | Cross Country Healthcare misses top-line and bottom-line estimates; cancels earnings call, suspends guidance due to pending transaction |
| 2024-05-09 | -10.1% | legal | SEC EDGAR | CCRN 8-K: 8.01 (SEC Filing) |
| 2026-03-04 | +10.0% | earnings | Seeking Alpha | Cross Country Healthcare Non-GAAP EPS of -$0.06 misses by $0.09, revenue of $236.8M misses by $17.5M |
| 2026-03-04 | +10.0% | legal | SEC EDGAR | CCRN 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-03-04 | +10.0% | earnings | Quiver Quantitative | Cross Country Healthcare Inc. (CCRN) Stock Falls on Q4 2025 Earnings - Quiver Quantitative |
| 2026-03-04 | +10.0% | earnings | Yahoo Finance | Cross Country Healthcare (CCRN) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance |
| 2024-07-29 | +9.6% | legal | SEC EDGAR | CCRN 8-K: 1.01, 2.03 (SEC Filing) |
| 2025-09-04 | +9.5% | M&A | Seeking Alpha | Cross Country Health gains amid certifying compliance with FTC for Aya deal |
| 2026-03-05 | +9.4% | earnings | Seeking Alpha | Cross Country Healthcare, Inc. (CCRN) Q4 2025 Earnings Call Transcript |
| 2025-11-14 | +8.0% | M&A | Investing.com | Cross Country Healthcare stock falls as Aya deal faces uncertainty - Investing.com |
| 2025-04-03 | +7.9% | legal | Seeking Alpha | Cross Country Healthcare: The FTC's Second Request Has Created An Arbitrage Opportunity |
| 2025-04-03 | +7.9% | legal | Seeking Alpha | Cross Country Healthcare: The FTC's Second Request Created An Arbitrage Opportunity (CCRN) - Seeking Alpha |
| 2025-10-09 | -7.9% | M&A | Seeking Alpha | Cross Country Healthcare falls amid report on FTC review of Aya deal |
| 2025-10-09 | -7.9% | M&A | Seeking Alpha | Cross Country Healthcare falls amid report on FTC review of Aya deal (CCRN:NASDAQ) - Seeking Alpha |
| 2026-04-06 | +6.9% | news | Zacks | 5 Broker-Liked Stocks Worth Tracking Amid the Middle East Conflict |
| 2021-06-09 | +6.5% | legal | SEC EDGAR | CCRN 8-K: 5.02 (SEC Filing) |
| 2023-05-03 | +6.4% | legal | SEC EDGAR | CCRN 8-K: 2.02, 7.01, 8.01 (SEC Filing) |
| 2022-08-16 | +6.3% | legal | SEC EDGAR | CCRN 8-K: 8.01 and (SEC Filing) |
| 2025-03-05 | -6.2% | earnings | Seeking Alpha | Cross Country Healthcare Non-GAAP EPS of $0.04, revenue of $309.9M |
| 2025-03-05 | -6.2% | legal | SEC EDGAR | CCRN 8-K: 2.02, 7.01 (SEC Filing) |
| 2021-11-19 | +6.1% | legal | SEC EDGAR | CCRN 8-K: 1.01, 2.03 (SEC Filing) |
| 2023-02-22 | -6.0% | legal | SEC EDGAR | CCRN 8-K: 2.02, 7.01 (SEC Filing) |
| 2021-06-14 | +5.9% | legal | SEC EDGAR | CCRN 8-K: 1.01, 2.01, 2.03, 3.02, 8.01 (SEC Filing) |
| 2026-03-19 | +5.6% | analyst | MT Newswires | Cross Country Healthcare Shares Rise After Wedbush Upgrade |
| 2026-03-19 | +5.6% | analyst | MT Newswires | Wedbush Upgrades Cross Country Healthcare to Outperform From Neutral, Raises Price Target to $15 From $11 |
| 2024-05-01 | -5.5% | legal | SEC EDGAR | CCRN 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-02-21 | -4.9% | legal | SEC EDGAR | CCRN 8-K: 5.02 (SEC Filing) |
| 2024-02-21 | -4.9% | legal | SEC EDGAR | CCRN 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-12-11 | +4.9% | M&A | Seeking Alpha | Cross Country Healthcare: The Failed Merger Is Disappointing, But Selling Here Would Be A Mistake |
| 2025-12-11 | +4.9% | M&A | Seeking Alpha | Cross Country Healthcare: Failed Merger Disappointing, But Selling Here Would Be A Mistake - Seeking Alpha |
| 2024-11-05 | +4.6% | earnings | Seeking Alpha | Cross Country Healthcare Q3 2024 Earnings Preview |
| 2025-03-06 | -4.3% | M&A | Seeking Alpha | Cross Country Healthcare falls on report about FTC review of Aya deal |
| 2024-09-27 | -4.3% | news | Seeking Alpha | Ensign set to join S&P MidCap 400; Curbline Properties, TransMedics to join S&P SmallCap 600 |
| 2026-01-02 | +4.2% | legal | SEC EDGAR | CCRN 8-K: 5.02 and (SEC Filing) |
| 2025-10-14 | +4.1% | M&A | Seeking Alpha | As The Clock Winds Down, Cross Country Healthcare Is At Its Cheapest Levels Since The Merger Announcement |
| 2022-04-07 | +4.0% | legal | SEC EDGAR | CCRN 8-K: 5.02, 7.01 (SEC Filing) |
| 2024-11-06 | +3.9% | earnings | Seeking Alpha | Cross Country Healthcare Non-GAAP EPS of $0.12 beats by $0.02, revenue of $315.12M beats by $4.9M |
| 2024-11-06 | +3.9% | legal | SEC EDGAR | CCRN 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-03-30 | -3.8% | legal | SEC EDGAR | CCRN 8-K: 5.02 (SEC Filing) |
| 2026-03-30 | -3.8% | legal | Stock Titan | [ARS] CROSS COUNTRY HEALTHCARE INC SEC Filing - Stock Titan |
| 2026-03-30 | -3.8% | executive | Stock Titan | Cross Country Healthcare (CCRN) appoints Amiee Hawkins as new COO - Stock Titan |
| 2026-03-30 | -3.8% | legal | Stock Titan | CCRN SEC Filings - Cross Ctry Healthcare Inc 10-K, 10-Q, 8-K Forms - Stock Titan |
| 2024-09-10 | -3.6% | news | Yahoo Finance | Should You Consider Selling Cross Country Healthcare (CCRN)? - Yahoo Finance |
| 2026-03-03 | +3.6% | earnings | Seeking Alpha | Cross Country Healthcare Q4 2025 Earnings Preview |
| 2022-11-17 | +3.3% | legal | SEC EDGAR | CCRN 8-K: 5.02 (SEC Filing) |
| 2025-12-15 | -3.3% | executive | Seeking Alpha | Cross Country Healthcare names co-founder Clark as CEO |
| 2025-12-15 | -3.3% | legal | SEC EDGAR | CCRN 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-12-15 | -3.3% | executive | GuruFocus | Cross Country Healthcare (CCRN) Appoints New CEO Amid Leadership Change - GuruFocus |
| 2026-01-29 | +3.3% | legal | SEC EDGAR | CCRN 8-K: 5.08 and 8.01 (SEC Filing) |
| 2026-04-04 | +3.2% | news | Simply Wall St. | How The Cross Country Healthcare (CCRN) Story Is Shifting With Margin Goals And Travel Nurse Demand |
| 2026-04-04 | +3.2% | news | Yahoo Finance | How The Cross Country Healthcare (CCRN) Story Is Shifting With Margin Goals And Travel Nurse Demand - Yahoo Finance |
| 2026-04-04 | +3.2% | legal | Stock Titan | CCRN SEC Filings - Cross Ctry Healthcare Inc 10-K, 10-Q, 8-K Forms - Stock Titan |
| 2021-12-16 | +3.1% | legal | SEC EDGAR | CCRN 8-K: 8.01 (SEC Filing) |
| 2025-08-06 | -3.1% | earnings | Seeking Alpha | Cross Country Healthcare Non-GAAP EPS of -$0.01 misses by $0.07, revenue of $274M misses by $18.19M |
| 2025-08-06 | -3.1% | legal | SEC EDGAR | CCRN 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-03-20 | +3.0% | news | Simply Wall St. | How The Narrative Is Shifting For Cross Country Healthcare (CCRN) After Mixed Margin Expectations |
| 2026-03-20 | +3.0% | news | Yahoo Finance | How The Narrative Is Shifting For Cross Country Healthcare (CCRN) After Mixed Margin Expectations - Yahoo Finance |
| 2025-02-21 | -3.0% | M&A | Seeking Alpha | Cross Country Healthcare/Aya get 2nd request from FTC on deal |
| 2025-02-21 | -3.0% | legal | SEC EDGAR | CCRN 8-K: 8.01 (SEC Filing) |
| 2024-08-01 | -2.9% | earnings | Seeking Alpha | Cross Country Healthcare, Inc. (CCRN) Q2 2024 Earnings Call Transcript |
| 2024-07-31 | -2.9% | legal | SEC EDGAR | CCRN 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-02-20 | +2.8% | news | DirectorsTalk Interviews | Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Exploring the 18.78% Potential Upside for Investors - DirectorsTalk Interviews |
| 2022-03-22 | +2.5% | legal | SEC EDGAR | CCRN 8-K: 1.01, 2.03 (SEC Filing) |
| 2025-06-30 | +2.5% | M&A | Seeking Alpha | Cross Country Healthcare: At This Price, The Pending Acquisition Is Worth Betting On (Rating Upgrade) |
| 2025-06-30 | +2.5% | M&A | Seeking Alpha | Cross Country Healthcare: At This Price, The Pending Acquisition Is Worth Betting On (Rating Upgrade) - Seeking Alpha |
| 2025-09-18 | +2.5% | news | Seeking Alpha | Cross Country Healthcare gains on speculation it wasn't subject of FTC meeting |
| 2026-03-10 | -2.5% | legal | SEC EDGAR | CCRN 8-K: 5.02 and (SEC Filing) |
| 2026-03-10 | -2.5% | earnings | Stock Titan | Healthcare workforce company teams with nonprofit to help vulnerable kids - Stock Titan |
| 2026-03-10 | -2.5% | news | TipRanks | Cross Country Healthcare Announces Key Executive Leadership Changes - TipRanks |
| 2023-10-02 | +2.3% | legal | SEC EDGAR | CCRN 8-K: 1.01, 2.03 (SEC Filing) |
| 2024-02-22 | -2.3% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2026-04-07 | -2.1% | news | Zacks | Zacks.com featured highlights include Cable One, Phillips 66, Archer Daniels Midland, CVR Energy and Cross Country Healthcare |
| 2026-04-21 | +2.1% | executive | Business Wire | Cross Country Appoints Chris Tyrell as Chief Information Officer to Support Next Phase of Enterprise AI and Platform Strategy |
| 2025-07-30 | -2.0% | news | Seeking Alpha | Cross Country Healthcare drops amid news of FTC meeting next week |
| 2022-05-04 | -2.0% | legal | SEC EDGAR | CCRN 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-03-17 | -1.9% | legal | SEC EDGAR | CCRN 8-K: 5.02 and (SEC Filing) |
| 2026-02-23 | +1.8% | executive | Stock Titan | Meetings with CFO: Cross Country Healthcare at two investor events - Stock Titan |
| 2025-07-28 | +1.8% | M&A | Investing.com | Cross Country Healthcare’s SWOT analysis: stock faces merger scrutiny - Investing.com |
| 2026-04-23 | -1.8% | executive | Business Wire | Cross Country Appoints Darrick Sogabe as Chief Product Officer, Advancing the Company’s Growing Technology Portfolio |
| 2021-09-14 | -1.7% | earnings | Zacks Investment Research | What date does Cross Country Healthcare's (CCRN) report Earnings - Earnings Calendar & Announcement - Zacks Investment Research |
| 2021-05-14 | +1.6% | legal | SEC EDGAR | CCRN 8-K: 8.01 and (SEC Filing) |
| 2026-04-02 | +1.6% | news | Stock Titan | Cross Country (NASDAQ: CCRN) GC awarded 33,644 restricted shares - Stock Titan |
| 2026-04-02 | +1.6% | news | Stock Titan | [Form 4] CROSS COUNTRY HEALTHCARE INC Insider Trading Activity - Stock Titan |
| 2026-04-02 | +1.6% | executive | Stock Titan | Cross Country Healthcare (CCRN) COO awarded 15,958 RSUs and has 43,953 shares - Stock Titan |
| 2026-04-02 | +1.6% | news | Stock Titan | CROSS COUNTRY (NASDAQ: CCRN) executive gets 21,024 RSUs, 2,462 shares withheld for tax - Stock Titan |
| 2026-04-02 | +1.6% | executive | Stock Titan | CROSS COUNTRY HEALTHCARE (NASDAQ: CCRN) CFO awarded 47,873 RS shares, 5,313 withheld for taxes - Stock Titan |
| 2026-04-02 | +1.6% | news | Stock Titan | [DEFR14A] CROSS COUNTRY HEALTHCARE INC Revised Proxy Statement - Stock Titan |
| 2026-03-12 | -1.5% | news | Insider Monkey | Does Cross Country Healthcare (CCRN) Have Strong Fundamentals? |
| 2026-03-12 | -1.5% | news | Insider Monkey | Does Cross Country Healthcare (CCRN) Have Strong Fundamentals? - Insider Monkey |
| 2026-04-09 | -1.5% | news | Stock Titan | Dimensional Fund Advisors (CCRN) files 5.0% stake — 1,609,925 shares disclosed - Stock Titan |
| 2024-10-15 | +1.3% | news | Seeking Alpha | Cross Country Healthcare: The Strong Balance Sheet Provides A Sufficient Margin Of Safety |
| 2025-07-31 | +1.3% | news | Seeking Alpha | Cross Country Healthcare gains on report it likely won't be subject of FTC meeting |
| 2022-02-23 | -1.2% | legal | SEC EDGAR | CCRN 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-05-16 | -1.2% | legal | SEC EDGAR | CCRN 8-K: 5.02 (SEC Filing) |
| 2023-04-18 | +1.1% | legal | SEC EDGAR | CCRN 8-K: 1.01, 2.03 (SEC Filing) |
| 2022-11-02 | +1.0% | legal | SEC EDGAR | CCRN 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-09-03 | +1.0% | legal | SEC EDGAR | CCRN 8-K: 8.01 (SEC Filing) |
| 2024-05-11 | +0.9% | earnings | MarketBeat | Cross Country Healthcare (CCRN) Stock Forecast and Price Target 2026 $CCRN - MarketBeat |
| 2025-02-28 | -0.9% | M&A | Seeking Alpha | Cross Country Healthcare shareholders OK acquisition by Aya |
| 2025-02-28 | -0.9% | legal | SEC EDGAR | CCRN 8-K: 5.07, 8.01 (SEC Filing) |
| 2026-03-26 | +0.7% | news | Stock Titan | Vanguard disaggregates holdings; Cross Country Healthcare (NASDAQ: CCRN) shows 0 shares - Stock Titan |
| 2025-09-30 | -0.6% | legal | SEC EDGAR | CCRN 8-K: 5.08 and 8.01 (SEC Filing) |
| 2023-01-05 | -0.6% | legal | SEC EDGAR | CCRN 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-04-17 | -0.3% | earnings | Business Wire | Cross Country Healthcare to Hold First Quarter 2026 Earnings Conference Call on Thursday, May 7, 2026 |
| 2026-04-17 | -0.3% | earnings | Stock Titan | Cross Country Healthcare will post Q1 results after market close May 7 - Stock Titan |
| 2026-04-17 | -0.3% | legal | DirectorsTalk Interviews | Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating a 17.96% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews |
| 2026-04-17 | -0.3% | earnings | Stock Titan | Cross Country Healthcare (CCRN) schedules Q1 2026 earnings call for May 7 - Stock Titan |
| 2021-05-10 | +0.3% | legal | SEC EDGAR | CCRN 8-K: 5.02 and (SEC Filing) |
| 2025-05-07 | -0.2% | earnings | Seeking Alpha | Cross Country Healthcare Non-GAAP EPS of $0.06 misses by $0.01, revenue of $293.4M misses by $21.42M |
| 2025-05-07 | -0.2% | legal | SEC EDGAR | CCRN 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-09-19 | +0.2% | legal | SEC EDGAR | CCRN 8-K: 5.02 (SEC Filing) |
| 2025-01-23 | -0.2% | news | Seeking Alpha | Cross Country Healthcare says HSR filing pulled/refiled in sale to Aya Healthcare |
| 2022-11-22 | +0.2% | legal | SEC EDGAR | CCRN 8-K: 5.02, 8.01 (SEC Filing) |